{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:33:50Z","timestamp":1780511630620,"version":"3.54.1"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec013\">\n<jats:title>Background<\/jats:title>\n<jats:p><jats:italic>Daboia palaestinae<\/jats:italic> is a leading cause of snakebite envenomation in the eastern Mediterranean, with substantial mortality in the absence of antivenin. Current recommended antivenin dose is 50\u2009ml; however, antivenin is costly, may be difficult to obtain and is associated with substantial side effects. Thus, this study was designed to define the minimal effective antivenin dose and identify patients who can be safely managed without antivenin.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec014\">\n<jats:title>Methods<\/jats:title>\n<jats:p>This retrospective single-center study was conducted in adults with suspected or confirmed D. <jats:italic>palaestinae<\/jats:italic> envenomation. Patients were treated via our previously developed envenomation protocol: no antivenin use for local symptoms and dose scaling for mild or severe systemic symptoms \u2013 initially 10\u2009ml antivenin, with repeat dosing for ongoing systemic symptoms. The main outcomes measured were morbidity and mortality associated with this protocol. Secondary outcomes included assessing the demographics and clinical effects of snake envenomation and comparing between those who received antivenin and those who did not.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec015\">\n<jats:title>Results<\/jats:title>\n<jats:p>In total, 101 patients were included. A median of 45 minutes [interquartile range: 30\u201361 minutes] elapsed between snakebite and hospital admission, with no differences between groups. Among 52 patients receiving antivenin, 119 [60\u2013237] minutes elapsed between snakebite and initial antivenin administration, with a maximum of 1073 minutes to initial antivenin administration. Maximum until last antivenin was 3860 minutes.<\/jats:p>\n<jats:p>Median antivenin dose was 15 [10\u201322.5] ml, with 26\/52 (50.0%) requiring only 10\u2009ml. Two (2) patients developed an early antivenin immune reaction, with one developing anaphylaxis requiring invasive ventilation. Both received a single 10\u2009ml dose of antivenin prior to allergic reaction. Neither patient had a known history of exposure to serum or relevant allergic reaction. No patients died during hospitalization.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec016\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This cohort demonstrates that a dose-scaling antivenin protocol can be safely employed, reducing morbidity and costs. We recommend a randomized control trial comparing fixed dose regimen to an escalation protocol and development of similar protocols for envenomations due to other snake species.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0319119","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T17:41:09Z","timestamp":1750959669000},"page":"e0319119","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["A dose scaling antivenin protocol in treatment of Daboia palaestinae envenomation may reduce morbidity and costs"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4196-9937","authenticated-orcid":true,"given":"Daniel J.","family":"Jakobson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zurab","family":"Zakariashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo F.","family":"Galicia H.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abu Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel M.","family":"Glatstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9698-9965","authenticated-orcid":true,"given":"Frederic S.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"issue":"5","key":"pone.0319119.ref001","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0041-0101(02)00393-8","article-title":"Report of a WHO workshop on the standardization and control of antivenoms","volume":"41","author":"RDG Theakston","year":"2003","journal-title":"Toxicon"},{"issue":"1","key":"pone.0319119.ref002","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJMra2105228","article-title":"Snake Envenomation","volume":"386","author":"SA Seifert","year":"2022","journal-title":"N Engl J Med"},{"issue":"11","key":"pone.0319119.ref003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050218","article-title":"The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths","volume":"5","author":"A Kasturiratne","year":"2008","journal-title":"PLoS Med"},{"issue":"6","key":"pone.0319119.ref004","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3390\/toxins13060427","article-title":"Old World Vipers-A Review about Snake Venom Proteomics of Viperinae and Their Variations","volume":"13","author":"M Damm","year":"2021","journal-title":"Toxins (Basel)"},{"issue":"1","key":"pone.0319119.ref005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.toxicon.2004.04.006","article-title":"Evaluation of antivenom therapy in Vipera palaestinae bites","volume":"44","author":"Y Bentur","year":"2004","journal-title":"Toxicon"},{"issue":"1","key":"pone.0319119.ref006","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/15569543.2018.1477162","article-title":"Is there a benefit for administration of antivenom following local and mild systemic reactions to Daboia (Vipera) Palaestinae snake bites?","volume":"39","author":"AH Wang","year":"2018","journal-title":"Toxin Reviews"},{"issue":"2","key":"pone.0319119.ref007","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.wem.2022.03.004","article-title":"Latency of Symptom Progression in Mild Daboia palaestinae Envenomation","volume":"33","author":"M Avni-Maskit","year":"2022","journal-title":"Wilderness Environ Med"},{"issue":"11","key":"pone.0319119.ref008","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.3390\/toxins3111420","article-title":"Pharmacological aspects of Vipera xantina palestinae venom","volume":"3","author":"T Momic","year":"2011","journal-title":"Toxins (Basel)"},{"issue":"1","key":"pone.0319119.ref009","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0041-0101(69)90159-7","article-title":"Clinical manifestations and treatment of viper bite in Israel","volume":"7","author":"P Efrati","year":"1969","journal-title":"Toxicon"},{"issue":"3","key":"pone.0319119.ref010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/15563659709001209","article-title":"Delayed administration of Vipera xanthina palaestinae antivenin","volume":"35","author":"Y Bentur","year":"1997","journal-title":"J Toxicol Clin Toxicol"},{"issue":"6","key":"pone.0319119.ref011","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0041-0101(97)00173-6","article-title":"Preliminary evaluation of Vipera palaestinae snake bite treatment in accordance to the severity of the clinical syndrome","volume":"36","author":"IY Shemesh","year":"1998","journal-title":"Toxicon"},{"key":"pone.0319119.ref012","first-page":"315","article-title":"Observations of 125 cases of viper bite [Hebrew","volume":"63","author":"P Efrati","year":"1962","journal-title":"Harefua"},{"issue":"3","key":"pone.0319119.ref013","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3390\/toxins11030168","article-title":"Daboia (Vipera) palaestinae Envenomation in 123 Horses: Treatment and Efficacy of Antivenom Administration","volume":"11","author":"S Tirosh-Levy","year":"2019","journal-title":"Toxins (Basel)"},{"issue":"2","key":"pone.0319119.ref014","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4269\/ajtmh.24-0399","article-title":"Cost of Snakebite and Its Impact on Household Economy in Southern Nepal","volume":"112","author":"DP Pandey","year":"2024","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"pone.0319119.ref015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005612","article-title":"Dose of antivenom for the treatment of snakebite with neurotoxic envenoming: Evidence from a randomised controlled trial in Nepal","volume":"11","author":"E Alirol","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"pone.0319119.ref016","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4103\/0972-5229.158275","article-title":"High-dose versus low-dose antivenom in the treatment of poisonous snake bites: A systematic review","volume":"19","author":"RR Das","year":"2015","journal-title":"Indian J Crit Care Med"},{"key":"pone.0319119.ref017","first-page":"237","article-title":"The Notodontidae (Lepidoptera) of Israel","volume":"36","author":"GC M\u00fcller","year":"2005","journal-title":"Atalanta"},{"key":"pone.0319119.ref018","article-title":"Daboia palaestinae","author":"S Hraoui-Bloquet","year":"2009","journal-title":"The IUCN Red List of Threatened Species"},{"key":"pone.0319119.ref019","first-page":"355","article-title":"Herpetofaunal survey of Israel (1950\u201385)","volume-title":"The zoogeography of Israel: The distribution and abundance at a zoogeographical crossroad","author":"Y Yom-Tov","year":"1988"},{"key":"pone.0319119.ref020","volume-title":"A field guide to reptiles and amphibians of Israel","author":"A Bar","year":"2022"},{"issue":"10385","key":"pone.0319119.ref021","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0140-6736(23)00002-8","article-title":"Clinical aspects of snakebite envenoming and its treatment in low-resource settings","volume":"401","author":"DA Warrell","year":"2023","journal-title":"Lancet"},{"issue":"4","key":"pone.0319119.ref022","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/vec.12207","article-title":"A retrospective evaluation of Vipera palaestinae envenomation in 18 cats: (2006-2011)","volume":"24","author":"I Lenchner","year":"2014","journal-title":"J Vet Emerg Crit Care (San Antonio)"},{"key":"pone.0319119.ref023","doi-asserted-by":"crossref","first-page":"107029","DOI":"10.1016\/j.toxicon.2023.107029","article-title":"Severe, persistent thrombocytopenia in Crotalus horridus envenomation despite antivenom: A retrospective review","volume":"224","author":"W Trautman","year":"2023","journal-title":"Toxicon"},{"key":"pone.0319119.ref024","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.thromres.2023.07.005","article-title":"Reversible and transient thrombocytopenia of functional platelets induced by nose-horned viper venom","volume":"229","author":"M Dobaja Borak","year":"2023","journal-title":"Thromb Res"},{"issue":"11","key":"pone.0319119.ref025","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1007\/s00204-021-03154-5","article-title":"Viper venoms drive the macrophages and hepatocytes to sequester and clear platelets: novel mechanism and therapeutic strategy for venom-induced thrombocytopenia","volume":"95","author":"C Shen","year":"2021","journal-title":"Arch Toxicol"},{"issue":"22","key":"pone.0319119.ref026","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.3390\/molecules27227779","article-title":"Platelet Desialylation Is a Novel Mechanism and Therapeutic Target in Daboia siamensis and Agkistrodon halys Envenomation-Induced Thrombocytopenia","volume":"27","author":"C Zhang","year":"2022","journal-title":"Molecules"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0319119","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T17:41:23Z","timestamp":1750959683000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0319119"}},"subtitle":[],"editor":[{"given":"Timothy","family":"Omara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0319119","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,26]]}}}